DPA-714
CAS No. 958233-07-3
DPA-714 ( —— )
Catalog No. M25016 CAS No. 958233-07-3
DPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 205 | In Stock |
|
10MG | 335 | In Stock |
|
25MG | 566 | In Stock |
|
50MG | 806 | In Stock |
|
100MG | 1098 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDPA-714
-
NoteResearch use only, not for human use.
-
Brief DescriptionDPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM).
-
DescriptionDPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM). It is designed with a fluorine atom in its structure, allowing labelling with fluorine -18 and in vivo imaging using positron emission tomography. [18F]DPA-714 successfully assesses for the specific imaging of inflammation in various models of neuroinflammation and in a brain tumor model.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTSPO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number958233-07-3
-
Formula Weight398.5
-
Molecular FormulaC22H27FN4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:41.67 mg/mL (104.57 mM; Need ultrasonic)
-
SMILESCCN(CC)C(Cc1c2nc(C)cc(C)n2nc1-c(cc1)ccc1OCCF)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.James ML, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008 May;49(5):814-22.
molnova catalog
related products
-
(RS)-MCPG
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
-
(-)-5-Isopropyl-2-Me...
(-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.
-
Buquinolate
Buquinolate is an anticoccidial agent used in poultry, and the medicated chickens can produce higher levels of egg production and gain weight. Buquinolate does not interfere with the formation of immunity against coccidia.